No Data
12 Health Care Stocks Moving In Monday's Pre-Market Session
Wells Fargo Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Raises Target Price to $6
Rapt Therapeutics Price Target Raised to $6 From $4 at Wells Fargo
Wells Fargo Raises RAPT Therapeutics' Price Target to $6 From $4, Overweight Rating Maintained
Why RAPT Therapeutics Stock Gained Over 100% On Monday?
Trending Stocks Today | Direct Digital Shoots up 450.9%
browny_440 : CYN